Charly, France

Anna Bencsik-Reynier

This inventor holds 1 USPTO granted patent. Top assignees: Agence Francaise De Securite Sanitaire Des Aliments-Afssa, Biomerieux, Inc., Centre National De La Recherche Scientifique. Active years: 2010.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anna Bencsik-Reynier: Innovator in Prion Research

Introduction

Anna Bencsik-Reynier is a notable inventor based in Charly, France. She has made significant contributions to the field of prion research, particularly in the detection and diagnosis of prion-related pathologies. Her innovative work has led to the development of a unique patent that addresses critical health concerns.

Latest Patents

Anna holds a patent for a process of concentration by precipitation of PrP for detecting or diagnosing PrP. This process involves bringing together a tissue or biological fluid from an animal or human organism with an antibiotic from the aminoglycoside family, preferably streptomycin or its derivatives. The patent also discloses the use of such an antibiotic for eliminating PrP from biological samples and includes a kit for diagnosing pathologies associated with the presence of PrP. She has 1 patent to her name.

Career Highlights

Throughout her career, Anna has worked with prominent organizations, including Biomerieux, Inc. and the University Claude Bernard - Lyon 1. Her work in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Anna has collaborated with esteemed colleagues such as Anthony William Coleman and Patrick Shahgaldian. These partnerships have enriched her research and expanded the impact of her innovations in prion detection.

Conclusion

Anna Bencsik-Reynier is a pioneering inventor whose work in prion research has the potential to improve diagnostic methods and patient outcomes. Her contributions to science and innovation are commendable and continue to inspire future research in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…